Turkey's Pharma Market in 2025: TRY 430.8 Billion and USD 2.51 Billion in Exports

According to the Pharmaceutical Industry Employers' Union (İEİS), Turkey's pharmaceutical market reached TRY 430.8 billion in value and about 2.7 billion boxes in volume in 2025, with value growth of 32.7%. Reference medicines accounted for TRY 272.7 billion (0.95 billion boxes) and generic medicines for TRY 158.1 billion (1.71 billion boxes). The same source puts the world pharmaceutical market at USD 1.9 trillion in 2025, with Turkey ranking 19th globally.

Local production dominates in volume: domestically produced medicines reached TRY 238.6 billion and 2.46 billion boxes in 2025, while imported medicines stood at TRY 192.1 billion and 0.19 billion boxes. In other words, more than 9 out of every 10 boxes sold were made in Turkey, while the local share in value was around 55%, as imports weigh heavily in high-priced products. The biotechnological medicines market reached TRY 90.9 billion (33.3 million boxes), of which TRY 8.2 billion (11.7 million boxes) came from biosimilars.

On the trade side, Turkey's medicine exports closed 2025 at USD 2.51 billion, up 9.3%, and grew 128.7% over 2015–2025. Medicine imports rose 17.4% to USD 7.3 billion in 2025. According to IQVIA's Turkey Pharmaceutical Sector Report 2025, Hungary was the top export destination in 2024, followed by South Korea, Georgia, Iraq, Iran, Cyprus, Poland, Bulgaria, Germany and Azerbaijan, with the top 10 countries accounting for 61% of medicine exports. At CSC we closely follow these trade flows from Turkey to the region's markets.

Source: Pharmaceutical Industry Employers' Union (İEİS), "World and Turkey Pharmaceutical Market" page and Turkey Pharmaceutical Sector 2025 report (ieis.org.tr); IQVIA, Turkey Pharmaceutical Sector Report 2025 Summary (published by AIFD, aifd.org.tr).